Table 5.
Treatment type | Alcohol/drug use treatment service use† | Drug use treatment service use† | Opioid use treatment service use† | |||
---|---|---|---|---|---|---|
| ||||||
Adjusted odds ratio, AOR | AOR | 95% CI | AOR | 95% CI | AOR | 95% CI |
Race/ethnicity (vs. white) | ||||||
Black | 0.73 | 0.47–1.14 | 0.50 | 0.31–0.80 | 0.47 | 0.29–0.77 |
Native-American | 1.14 | 0.56–2.32 | 1.16 | 0.55–2.45 | 1.32 | 0.57–3.05 |
Native-Hawaiian/Pacific-Islander/Asian-American | 0.23 | 0.08–0.64 | 0.22 | 0.08–0.67 | 0.09 | 0.03–0.31 |
Mixed-race | 0.98 | 0.52–1.85 | 1.09 | 0.56–2.16 | 0.91 | 0.42–1.98 |
Hispanic | 0.81 | 0.55–1.20 | 0.75 | 0.49–1.14 | 0.79 | 0.48–1.30 |
| ||||||
Age in years (vs. 12–17) | ||||||
18–25 | 1.19 | 0.95–1.51 | 1.26 | 1.00–1.60 | 1.80 | 1.45–2.25 |
26–34 | 1.19 | 0.86–1.64 | 1.20 | 0.87–1.65 | 1.72 | 1.26–2.36 |
35–49 | 1.74 | 1.21–2.50 | 1.96 | 1.34–2.86 | 2.65 | 1.78–3.94 |
50+ | 1.33 | 0.70–2.50 | 1.27 | 0.63–2.56 | 2.34 | 1.19–4.60 |
| ||||||
Sex (female vs. male) | 1.03 | 0.81–1.31 | 1.04 | 0.80–1.36 | 1.30 | 0.96–1.76 |
| ||||||
Total annual family income (vs. <$50,000) | ||||||
$50,000–$74,999 | 0.82 | 0.60–1.14 | 0.83 | 0.59–1.18 | 0.68 | 0.46–1.02 |
$75,000+ | 1.11 | 0.81–1.53 | 1.16 | 0.85–1.57 | 1.10 | 0.79–1.54 |
| ||||||
Population density (vs. large metropolitan) | ||||||
Small metropolitan | 0.74 | 0.59–0.94 | 0.79 | 0.62–1.00 | 0.80 | 0.61–1.05 |
Nonmetropolitan | 1.02 | 0.59–1.78 | 1.16 | 0.66–2.04 | 1.15 | 0.64–2.06 |
| ||||||
Health insurance (vs. none) | ||||||
Private | 1.31 | 0.97–1.75 | 1.23 | 0.93–1.64 | 1.29 | 0.95–1.76 |
Public | 1.89 | 1.42–2.52 | 1.86 | 1.41–2.45 | 1.57 | 1.17–2.10 |
| ||||||
Heroin use disorder (yes vs. no) | 5.12 | 4.12–6.37 | 5.20 | 4.10–6.59 | 6.23 | 4.78–8.12 |
| ||||||
Major depressive episode – past year (yes vs. no) | 1.58 | 1.21–2.06 | 1.51 | 1.16–1.98 | 1.40 | 1.04–1.89 |
| ||||||
Nicotine dependence – current (yes vs. no) | 1.96 | 1.54–2.49 | 1.80 | 1.40–2.31 | 1.78 | 1.32–2.39 |
| ||||||
Alcohol use disorder – past year (yes vs. no) | 1.15 | 0.92–1.44 | 0.93 | 0.75–1.16 | 0.78 | 0.63–0.98 |
| ||||||
Other drug use disorder-past year** (yes vs. no) | 2.00 | 1.54–2.61 | 2.17 | 1.70–2.79 | 1.84 | 1.39–2.45 |
| ||||||
Year (vs. 2005) | ||||||
2006 | 1.45 | 0.91–2.31 | 1.55 | 0.93–2.56 | 1.25 | 0.74–2.12 |
2007 | 1.40 | 0.84–2.33 | 1.00 | 0.60–1.67 | 1.11 | 0.65–1.89 |
2008 | 1.03 | 0.66–1.62 | 0.99 | 0.63–1.56 | 1.02 | 0.62–1.69 |
2009 | 1.28 | 0.86–1.89 | 1.14 | 0.73–1.79 | 1.25 | 0.79–2.00 |
2010 | 1.29 | 0.83–2.00 | 1.04 | 0.66–1.62 | 0.88 | 0.55–1.42 |
2011 | 1.63 | 1.07–2.48 | 1.53 | 0.97–2.42 | 1.51 | 0.95–2.39 |
2012 | 1.59 | 1.10–2.32 | 1.56 | 1.06–2.30 | 1.67 | 1.11–2.50 |
2013 | 1.22 | 0.74–2.00 | 1.13 | 0.66–1.93 | 1.20 | 0.72–2.01 |
The sample was 5,977 (148 respondents with missing data on major depressive episode were excluded).
Other drug included illicit drugs other than opioid and heroin.
Each adjusted logistic regression included all variables listed in the first column. CI: confidence interval. AOR: adjusted odds ratio. Boldfaced: P<0.05.